Ketorolac (systemic) vs Neuromuscular-Blocking Agents (Nondepolarizing)

Interacting Drugs
Ketorolac (systemic)
vs
Neuromuscular-Blocking Agents (Nondepolarizing)
Security Level
Minor, Monitor Therapy
Mechanism
Neuromuscular-Blocking Agents (Nondepolarizing): Ketorolac (Systemic) may enhance the adverse/toxic effect of Neuromuscular-Blocking Agents (Nondepolarizing). Specifically, episodes of apnea have been reported in patients using this combination.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ketorolac (systemic) vs Neuromuscular-Blocking Agents (Nondepolarizing)